Delivery Order 75N93024D00004-75N93026F00002
Award Date 7/27/26
Potential Completion Date 7/26/27
Potential Value $2.4M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Manassas, VA 20110, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute of Allergy and Infectious Diseases issued a $4.3 million delivery order to American Type Culture Collection on July 1, 2026, under the Pre-Clinical Models of Infectious Diseases IDIQ for screening candidate countermeasures for seasonal and high pathogen avian influenza in a human lung microphysiological system. Place of performance is Manassas, VA. The order runs through June 30, 2027, and is priced on a cost-plus-fixed-fee basis with a ceiling value of $4,298,901. No...
- <p>The National Institute of Allergy and Infectious Diseases issued a $2,500 delivery order to American Type Culture Collection on January 11, 2019, under the In Vitro Assessments of Antimicrobial Activity (IVAAA) parent contract for in vitro assessments of antimicrobial activity.</p> <p>Place of performance is Manassas, Virginia. The order has a firm fixed price structure with an ultimate completion date of September 30, 2020. No set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order to American Type Culture Collection on January 11, 2019, with a ceiling value of $2,500 under the In Vitro Assessments of Antimicrobial Activity (IVAAA) IDIQ for in vitro assessments of antimicrobial activity.</p> <p>Place of performance is Manassas, VA 20110. The order is firm fixed price with an ultimate completion date of September 30, 2020. No set-aside was used.</p>
- <p>The National Institute of Allergy and Infectious Diseases issued a delivery order (Task Order C03) to Sri International on February 20, 2026, with a ceiling value of $721,961.69 under a firm fixed price structure.</p> <p>Place of performance is Menlo Park, CA. The order carries an ultimate completion date of February 19, 2032. No set-aside was used.</p>
- The National Institute of Allergy and Infectious Diseases issued a delivery order to the University of Texas Medical Branch at Galveston on July 27, 2026, with a ceiling value of $6,285,771 for screening candidate countermeasures for viral hemorrhagic fever using liver-based organ-on-a-chip microphysiological systems in high-level containment. The order is issued under the Pre-Clinical Models of Infectious Diseases IDIQ. Place of performance is Galveston, TX, with an ultimate completion date...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on August 25, 2015, exercising Option 4 Year 5 (Period 9/1/2019–8/31/2020) for $1,999,679 in administrative and technical support for radiation/nuclear medical countermeasure product development activities under a cost-plus-fixed-fee structure. The order supports all other task orders under the base contract through administrative and technical activities. Place of performance is Menlo Park,...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to The Geneva Foundation on January 11, 2019, with a ceiling value of $142,614.09 under the In Vitro Assessments of Antimicrobial Activity (IVAAA) indefinite delivery vehicle for in vitro assessments of antimicrobial activity. The order requires determination of antiviral inhibitory effects and cytotoxicity of experimental antiviral compounds against viruses, including rapidly emerging viruses utilizing the same...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Sri International on April 1, 2020, with a ceiling value of $8.95 million for nonclinical services supporting the development of interventional agents for infectious diseases. The order is issued under the Nonclinical Services for Development of Interventional Agents parent IDIQ. Work is performed in Menlo Park, CA, with an ultimate completion date of March 31, 2021. The contract is priced on a...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $2,500 delivery order against the In Vitro Assessments of Antimicrobial Activity indefinite-delivery/indefinite-quantity contract to American Type Culture Collection, doing business as Atcc, located in Manassas, Virginia. The delivery order is for in vitro assessment for antimicrobial activity as described in the master IDIQ and will be performed by Atcc...
- The National Institute of Allergy and Infectious Diseases issued a delivery order to Advanced Bioscience Laboratories, Inc., on September 6, 2017, with a ceiling value of $110,115.92 under the Preclinical Services for Biopharmaceutical Product Development IDIQ. Place of performance is Rockville, MD. The order was initially set to run through February 10, 2018 and was extended to April 13, 2018 at no additional cost. Pricing is cost plus fixed fee. No set-aside was used for this order.